LMAT

LMAT

USD

LeMaitre Vascular Inc. Common Stock

$86.820+3.820 (4.602%)

即時價格

Healthcare
Medical Instruments & Supplies
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$83.000

最高

$89.010

最低

$81.570

交易量

0.06M

公司基本面

市值

2.0B

行業

Medical Instruments & Supplies

國家

United States

交易統計

平均交易量

0.17M

交易所

NGM

貨幣

USD

52週範圍

最低 $71.42當前 $86.820最高 $109.58

AI分析報告

最後更新: 2025年10月30日
由AI生成數據來源: Yahoo Finance, Bloomberg, SEC

LMAT Analysis: LeMaitre Vascular Faces Key Inflection Point Ahead of Earnings

Price Action: Volatility and Support Testing

LeMaitre Vascular (LMAT) has experienced a rollercoaster ride over the past three months. The stock surged from $81 to $93.04 in early August (+15%) but later dropped to $84.66 in late September (-9%), only to stabilize near $88.55 as of October 30. Key patterns to note:

  • Support Zone Alert: The stock hovers near $89.16, a critical support level. Recent lows on October 29 ($88.33) and October 30 ($87.82) suggest sellers are testing this level.
  • Volume Contrasts: Surge days (August 6: +18%, volume 428,600) contrast sharply with the 509,700 volume crash on August 26 (-5%), indicating emotional retail trader involvement.
  • Technical Tug-of-War: Mixed signals - the MACD "death cross" warns of bearish momentum, while the OBV spike on October 30 shows sudden buying pressure.

Sentiment: Analysts Push Against Market Skepticism

  • Positive Catalyst: Barrington Research reiterated its $95 price target on October 15, implying 7.2% upside from current levels. 8 analysts collectively project a $104.62 average target (+17.9% potential).
  • Earnings Countdown: The company’s Q3 results (November 6) create a natural inflection point. Historical volatility around reporting dates could amplify moves post-announcement.
  • Market Disconnect: Despite the analyst optimism, the stock underperforms its 52-week high ($109.58) by 19% and trades below its P/E ratio of 40.81, which the model flags as "neutral" (not overvalued nor undervalued).

Predictive Outlook: AI Detects Short-Term Momentum

AI models project a cautious upside over 3 days:

  • Day 1: +0.2% (flat move, low confidence)
  • Day 2: +2.6% (strongest signal)
  • Day 3: +2.3% (sustained momentum) Combined with the $91.57 AI target, this suggests potential rebound energy if support at $89.16 holds. However, the technical DMI (-DI 12.5 vs. +DI 8.8) warns of unresolved bearish pressure.

Strategic Guidance: Play the Range, Watch Debt Shadows

Entry Opportunities: If volume surges above 150,000, consider nibbling at shares near the support cluster ($89.09-$90.30). The technical setup favors a bounce, but the high debt-to-equity ratio (51.

相關新聞

Analyst Upgrades

Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular with a Outperform and maintains $95 price target.

查看更多
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target
GlobeNewswire

LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025

BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market

查看更多
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025

AI預測Beta

AI推薦

看漲

更新於: 2025年11月10日 上午10:37

看跌中立看漲

63.1% 信心度

風險與交易

風險級別3/5
中等風險
適合
溫和
交易指南

入場點

$86.47

獲利了結

$88.43

止損

$78.02

關鍵因素

DMI 顯示熊市趨勢 (ADX:6.4, +DI:22.2, -DI:22.5),建議謹慎
當前價格非常接近支撐位 ($86.60),表明強勁的買入機會
交易量是平均值 (2,018) 的 9.9 倍,表明極強的買入壓力
MACD 0.0663 在信號線 0.0715 下方,表示看跌交叉

保持更新

設定價格提醒,獲取AI分析更新和即時市場新聞。